Evofem Biosciences Inc EVFM Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jun 14, 2021 (filed on Jun 14, 2021)

Insider Name:

O'Brien Anthony Stephen

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

8,140

Price:

$1.31
Jun 11, 2021 (filed on Jun 14, 2021)

Insider Name:

Rarick Lisa Dale

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,000

Price:

$1.20
Jun 11, 2021 (filed on Jun 11, 2021)

Insider Name:

Barrans Russell

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

18,180

Price:

$1.14
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

File Justin J.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

24,500

Price:

$1.03
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

Pelletier Saundra L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

50,000

Price:

$1.03
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$1.03
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,120

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Barrans Russell

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-31,480

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Culwell Kelly

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,061

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

File Justin J.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,280

Price:

$0.86

Filings by filing date

Jun 11, 2021 (filed on Jun 14, 2021)

Insider Name:

Rarick Lisa Dale

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

5,000

Price:

$1.20
Jun 14, 2021 (filed on Jun 14, 2021)

Insider Name:

O'Brien Anthony Stephen

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

8,140

Price:

$1.31
Jun 11, 2021 (filed on Jun 11, 2021)

Insider Name:

Barrans Russell

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

18,180

Price:

$1.14
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

File Justin J.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

24,500

Price:

$1.03
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

Pelletier Saundra L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

50,000

Price:

$1.03
Jun 10, 2021 (filed on Jun 10, 2021)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

10,000

Price:

$1.03
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,120

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Barrans Russell

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-31,480

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

Culwell Kelly

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,061

Price:

$0.86
May 20, 2021 (filed on May 21, 2021)

Insider Name:

File Justin J.

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3

# or value acquired/disposed of:

-42,280

Price:

$0.86

News

Biz Brief

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEC

Company Contact

Address:	12400 High Bluff Dr Ste 600 SAN DIEGO CA 92130-3077
Tel:	1-858-5501900
Website:	https://www.evofem.com
IR:	See website

Key People

Saundra L. Pelletier President, Chief Executive Officer, Director	Justin J. File Chief Financial Officer	Alexander A. Fitzpatrick Executive Vice President, General Counsel, Secretary
Russell Barrans Chief Commercial Officer	Kelly Culwell Chief Medical Officer

Business Overview

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing and commercializing products to address needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from sexually transmitted infections (STIs). The Company's product, Phexxi vaginal gel, is an on-demand prescription contraceptive gel for women. Its pipeline product candidate, EVO100 vaginal gel, is evaluated for the prevention of chlamydia trachomatis infection and Neisseria gonorrhoeae in women. The Company also focuses on the development of EVO200 vaginal gel, its candidate for the reduction of recurrent bacterial vaginosis (BV).Its subsidiaries include Evofem Biosciences Operations Inc, Evofem Inc and Evofem Ltd.

Financial Overview

For the three months ended 31 March 2021, EvofemBiosciences Inc revenues increased from $0K to $1.1M. Netloss increased from $19.1M to $46.2M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Higher net lossreflects Selling & Marketing - Balancing value increasefrom $7.3M to $29.5M (expense), Research and DevelopmentExpense - Bal increase of 77% to $6.6M (expense).

Employees:	147 as of Feb 28, 2021

Reporting Currency:	U.S. Dollars
Enterprise value:	$152.89M as of Mar 31, 2021
Annual revenue (TTM):	$1.55M as of Mar 31, 2021
EBITDA (TTM):	-$128.73M as of Mar 31, 2021
Net annual income (TTM):	-$169.31M as of Mar 31, 2021
Free cash flow (TTM):	-$126.79M as of Mar 31, 2021
Net Debt Last Fiscal Year:	$33.60M as of Mar 31, 2021
Shares outstanding:	102,835,674 as of Apr 30, 2021
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Evofem Biosciences Inc (OQ:EVFM)